The Hybrid International Conference on Pharmacology and Therapeutics, organized by the International Research Conference, will take place on October 7-8, 2026, in New York, USA. This conference aims to facilitate the exchange of experiences and research findings among leading academic scientists, researchers, and scholars in Pharmacology and Therapeutics. It offers a premier interdisciplinary platform for presenting the latest innovations, trends, and concerns in these fields. The conference program will feature diverse scholarly events spread over the duration, catering to the interests of students, academics, and industry researchers. Attendees can expect high-quality presentations and discussions addressing practical challenges and innovative solutions in Pharmacology and Therapeutics.

Read on waset.org

The International Research Conference, a federated organization, will host the Hybrid International Conference on Pharmacology and Therapeutics on July 12-13, 2025, in New York, USA. This conference aims to facilitate the exchange of experiences and research outcomes among leading academic scientists, researchers, and scholars in the field of Pharmacology and Therapeutics. It offers a premier interdisciplinary platform for presenting recent innovations, trends, and concerns within these fields. The conference program will feature diverse scholarly events spread over the allotted time, catering to the interests and needs of students, academics, and industry researchers. Attendees can expect high-quality presentations and discussions on practical challenges and adopted solutions in Pharmacology and Therapeutics.

Read on waset.org

The International Conference on Pharmacology and Therapeutics, scheduled digitally for October 10-11, 2024, in New York, United States, is organized by the International Research Conference, a federated organization dedicated to curating diverse scholarly events of exceptional quality. This conference aims to facilitate the exchange of experiences and research outcomes among leading academic scientists, researchers, and scholars in the field of Pharmacology and Therapeutics. It offers a premier interdisciplinary platform for participants to present and discuss recent innovations, trends, concerns, and practical challenges encountered in these fields. The conference provides significant value for students, academics, and industry researchers interested in advancing Pharmacology and Therapeutics.

Read on waset.org

Oligo Chemistry & Therapeutics Online Symposium is sheduled on 27 September 2024.A dedicated online event discussing best practice oligo chemistry & therapeutics development techniques, methods, strategies & real-world applications.This programme takes a deep dive into best practice oligo chemistry & development approaches & technological advancements, bringing together thought leaders from across the globe for focused discussions & networking.Discuss the latest applications of these therapeutics in the clinical field including case studies from various disease areas and creating a discourse on what the next application may be. 

[Read on oxfordglobal.com](https://oxfordglobal.com/biologics/events/oligo-chemistry-therapeutics-online-symposium/book-now/)

The International Conference on Pharmacology and Therapeutics, set to take place digitally on June 03-04, 2024, in New York, United States, is organized by the International Research Conference—a federated organization committed to assembling a diverse array of high-quality scholarly events. This conference aims to convene leading academic scientists, researchers, and research scholars to exchange experiences and share research findings across all aspects of Pharmacology and Therapeutics. It serves as a premier interdisciplinary platform for participants to present and discuss the latest innovations, trends, concerns, and practical challenges encountered and solutions adopted in these fields. The event offers exceptional value for students, academics, and industry researchers interested in advancing Pharmacology and Therapeutics.

Read on waset.org

Synthetic Biology US 2024 convenes top omics experts, fostering a two-day event dedicated to accelerating synthetic biology tool development for effective therapeutics. Now in its 3rd year, the gathering features influential leaders sharing novel case studies and industry insights. Engage with global academia, research entities, and pharmaceutical representatives for groundbreaking discussions on innovative synthetic biology tools—enabling target discovery, production enhancement, AI/ML integration, and synthetic biology-based therapeutics. Save the date for this dynamic collaborative platform.

 [Read on oxfordglobal.com](https://oxfordglobal.com/synthetic-biology-us/?utm_campaign=Omics%20Series&utm_source=listingsite&utm_medium=eventlisting&utm_term=homepage&utm_content=synbious2024)

International Conference on Oncolytic Virus Therapeutics(ICOVT) aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Oncolytic Viruses and Immunotherapy. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Oncolytic Viruses and Immunotherapy. Oncolytic Virus is an international platform for presenting research about Virus Outbreaks, control and Therapy. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health. Oncolytic viruses are a novel class of anti-cancer agents which in many cases have entered clinical trials. These viruses are capable of attacking cancer cells in a distinctive manner leading to cell-specific and targeted tumor therapy.

Read on conferenceonline.net

Society is undergoing rapid changes: aging demographics, medical breakthroughs, and evolving consumer preferences. To navigate these shifts, we must foster innovation across the healthcare sector. This entails reimagining care for an aging population, creating equitable access to therapeutics, and aligning incentives for collaborative efforts. The 2023 Health Innovation Summit offers a platform to exchange ideas and prepare for the challenges ahead.

Read on oliverwyman.com

The Spatial Biology Europe 2023 Conference connecting global academic & research organisations as well as pharma representatives for high-level discussion on the latest innovations in spatial research & technologies. This 2-day event explores spatial research: from the application of spatial technologies in biology through to topical updates from spatial genomics, transcriptomics, metabolomics and spatial bioinformatics. The 2023 event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook. Benefits to attending includes Overcome challenges in Spatial Biology Data Analysis ,Learn From Applications On Therapeutic Areas, Explore the latest Spatial Technologies and Gain insights into Spatial Multi-Omics applications. Maximize your experience with our fully featured Event App, with selected presentations available to watch on-demand and extensive networking features.

Read on oxfordglobal.co.uk

The RNA Therapeutics & Delivery US 2023 Conference will be held on 08 - 09 June 2023, Boston, USA. Gain invaluable insights into the latest formulation, design & delivery of RNA therapeutics. Key opinion leaders will be addressing novel mRNA structures, therapeutic case studies and advanced delivery strategies for RNA. Cross four in-depth sessions the latest improvements pushing the industry forward will be addressed: from stability & clinical manufacturing, RNA computational design approaches, through to case studies & recent developments in RNA delivery platforms. Stay at the forefront of the growing interest in this area and hear case studies from the applications of RNAs in therapeutics and delivery challenges & future opportunities. A two-day event packed with leading speakers, research and cutting-edge presentations on the latest innovations in RNA formulation & CMC: presentations will delve into nanoparticle-based formulations, particle characterization, purification methods and clinical manufacturing updates. Discover collaborative solutions to next generation RNA structures & design, and insights into novel technologies. Presentations will tap into AI/ML and computational-assisted design approaches for siRNA and mRNA, formulation design for optimal delivery, and novel technologies. Join us for interactive panel discussions, roundtables & workshops with like-minded experts  on  ‘Optimizing RNA Formulation Development’, RNA Therapeutics: Current State & Future Direction’, ‘Opportunities And Challenges For Next Generation RNA Technologies And Non-Viral Delivery Systems’, and many more.

Read on oxfordglobal.co.uk

The RNA Leaders World Congress delivers the latest advances in RNA chemistry, clinical updates, new therapies and the services partners who are helping to deliver drugs to patients. RNA medicines are at a critical moment in time. mRNA vaccines dominate the headlines in the wake of the COVID-19 pandemic. But huge advances are also being made in RNAi and antisense technologies. Our understanding of RNA chemistry continues to mature. Delivery tools are increasingly sophisticated and impactful. Advances in genomics and gene editing are driving new approaches. And exciting work targeting RNA with small molecules is emerging.

With that in mind, we can’t wait to bring the community together, face-to-face, for the second annual RNA Leaders Europe Congress. So, if you’re passionate about all things RNA do join us, and more than 600 biotech, pharmaceutical, investment, regulatory and scientific professionals at the RNA Leaders Europe Congress. You’ll hear the latest advances in RNA chemistry, get clinical updates from the companies developing new therapies and source the services partners who are helping to deliver drugs to patients.

Read on lsxleaders.com

The demand for cell and gene therapies is growing at an exponential rate as an increasing number of drug developers scale up their supply chain operations as their pipelines grow and more candidates are accelerated into the clinic.

As numerous therapies progress to commercial levels, there has never been a more important time to synergize your supply and clinical efforts to future-proof the scalability, accessibility and patient-centricity of your cell or gene therapy treatment, particularly in an acute period of geopolitical global disruption.

Read on immunotherapy.com

With the support of 2023 Cardiology Committee Members, we have scheduled our “9th World Congress on Cardiology and Cardiovascular Therapeutics” around the theme ‘Highlighting Modern Techniques in Cardio and Cardiovascular Diseases. CARDIOLOGY2023 is a premier educational event in the field of Cardiovascular Therapeutics and Cardiology that rotates between continents and is organized in collaboration with national and international Cardiac societies and associations. The World Congress on Cardiology and Cardiovascular Therapeutics is targeted to the international Cardiology, Cardiac Surgery, and Cardiovascular community as well as the other healthcare professionals involved in multidisciplinary Heart Care; thus, enabling professionals from worldwide to exchange their views on a wide variety of topics affecting heart and those suffering from heart diseases around the globe. CARDIOLOGY2023 exists to advance the science and art of medicine and surgery related to the care of the heart. CARDIOLOGY2023 works with many other organizations to achieve its aims of supporting patients and improving standards.

Read on cardio.cardiologymeeting.com

USG-United Scientific Group, A Non-Profit Organization, delighted to announce the 4th International Conference on Medical Imaging and Therapeutics (Previously MICR) dedicated to clinical and medical research intrinsic to all imaging modalities, including optical, ultrasound, magnetic resonance, x-ray computed tomography, nuclear imaging for diagnostic and treatment purposes.

Read on unitedscientificgroup.com

Incorporating healthcare providers’ perspectives in the clinical development process is important for delivering medical devices, diagnostics and pharmaceuticals with high levels of clinical utility. Well-designed healthcare preference studies with vignette-based profiles can demonstrate clinical utility in a cost-effective, time-efficient and robust manner. These studies address many questions for innovators planning to launch successful products. In this webinar, the speakers will discuss the methods used to demonstrate the clinical utility of medical products, and will explain how preference studies, such as conjoint analyses with physician survey data, fit into the armamentarium of techniques used to generate clinical utility evidence. They will provide an overview of conjoint analysis and describe the process of conducting a conjoint analysis study.

Read on xtalks.com